Coaching Dementia Caregivers to Master Care-Resistant Behavior
Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Oct 18, 2021
Trial Information
Current as of October 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a program designed to help family caregivers who are taking care of loved ones with dementia, especially those who resist help with daily activities. The goal is to see if a coaching program called CuRB-IT can improve the caregivers’ ability to manage challenging behaviors and provide better care. A total of 266 caregivers will participate, and they will be divided into two groups. One group will start the coaching right away, while the other group will wait 12 weeks before starting the program.
To be eligible for this trial, caregivers must be at least 18 years old and provide unpaid care to a family member aged 60 or older who has mild cognitive impairment or dementia. They should live with the person they are caring for or share cooking facilities and need to help with daily tasks. Participants will complete surveys and daily diaries to track their experiences throughout the study. This trial is currently recruiting participants, and it’s important to note that those who cannot read or speak English or lack internet access will not be eligible.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1)Caregiver of any race or gender who is aged \>18 years
- • 2) provides unpaid care,
- • 3) cares for a spouse/common-law, sibling, parent or grandparent (or in-law, aged 60+ years),
- • 4) lives with or shares cooking facilities with the care recipient,
- • 5) Care recipient has mild cognitive impairment or dementia as identified using the Quick Dementia Rating System instrument,
- • 6) the care provided consists of help with at least 2 Instrumental Activities of Daily Living or one Activity of Daily Living,
- • 7) the care recipient is resistant to receiving assistance with, or refuses to do, at least one instrumental or activity of daily living
- Exclusion Criteria:
- • 1) persons who cannot speak/read English
- • 2) who do not have reliable access to a smart phone or internet
About University Of Alabama At Birmingham
The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Birmingham, Alabama, United States
Patients applied
Trial Officials
Rita A Jablonski, PhD
Principal Investigator
University of Alabama at Birmingham
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials